Orencia 125MGML PFS 4S
Ended Awarded
- Contract number
- SPE2DX25FWLJV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $21,424
Award facts
- Contract value 100% obligated
- $21,423.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $21,423.78 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Orencia 125mg/mL pre-filled syringes (4-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of May 30, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency and serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's federal procurement activity demonstrates consistent capability in fulfilling competitive medical supply requirements across diverse therapeutic domains, with delivery orders ranging from minimal to substantial values. Orencia (abatacept) is a biologic immunosuppressant used in the treatment of rheumatoid arthritis and other autoimmune conditions, representing the type of specialized pharmaceutical commodity that supports military and veteran healthcare delivery under the Medical Supply Chain's procurement mandate.
Quick answers
Who was awarded contract SPE2DX25FWLJV?
SPE2DX25FWLJV was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 2, 2025.
How much is contract SPE2DX25FWLJV worth?
The government has obligated $21,424 on SPE2DX25FWLJV.
Is contract SPE2DX25FWLJV an order under another contract?
Yes. SPE2DX25FWLJV is a delivery order under SPE2DX15D6028, an indefinite delivery contract.
Was contract SPE2DX25FWLJV competed?
The extent of competition for SPE2DX25FWLJV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award